Back
Zevra Therapeutics Stock Predictions
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
49
ZVRA
Zevra Therapeutics
Last Price:
$9.19
Seasonality Move:
37.31%
7 Day Trial
ALL ACCESS PASS
$
7
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteZevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 7.6% based on the past 10 years of stock performance.
-
Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $9.26. The Score for ZVRA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 7.6% based on the past 10 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
49
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
506.3M
Price in USD:
9.26
Volume:
1.3M
Beta:
1.81
Technical Analysis
SMA50:
7.79
SMA100:
7.84
SMA200:
8.03
52-Wk Change:
96.19%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 9.26 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-19 | 8.57 | 8.91 | 8.92 | 8.51 |
| May-20 | 8.91 | 8.61 | 8.91 | 8.57 |
| May-21 | 8.55 | 8.66 | 8.84 | 8.41 |
| May-22 | 8.60 | 8.57 | 8.67 | 8.49 |
| May-23 | 8.45 | 8.65 | 8.68 | 8.43 |
| May-27 | 8.74 | 8.45 | 8.78 | 8.40 |
| May-28 | 8.44 | 8.33 | 8.47 | 8.21 |
| May-29 | 8.37 | 8.62 | 8.62 | 8.27 |
| May-30 | 8.63 | 8.55 | 8.63 | 8.38 |
| Jun-2 | 8.61 | 8.66 | 8.81 | 8.54 |
| Jun-3 | 8.68 | 8.87 | 8.94 | 8.56 |
| Jun-4 | 8.81 | 8.95 | 9.06 | 8.78 |
| Jun-5 | 8.97 | 8.83 | 9.11 | 8.78 |
| Jun-6 | 8.97 | 9.26 | 9.38 | 8.93 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.20 per share, an increase this year of $3.02 per share, and a decrease next year of $0.45 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.